alternative commercially available pfo closure devices Search Results


alternative commercially available pfo closure devices  (Biostar Inc)
86
Biostar Inc alternative commercially available pfo closure devices
Distribution of <t>Patent</t> <t>Foramen</t> <t>Ovale</t> <t>(PFO)</t> closure devices. This pie chart illustrates the proportional distribution of the different occluder devices used in the study cohort (N = 130). The Amplatzer PFO Occluder was the most utilized device (69.2%, N = 90), followed by Occlutech (20.8%, n = 27), Cardiofix (5.4%, n = 7), and Biostar (4.6%, n = 6). Data are presented as percentages and absolute patient counts.
Alternative Commercially Available Pfo Closure Devices, supplied by Biostar Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alternative+commercially+available+pfo+closure+devices/pmc13163734-49-11-19?v=Biostar+Inc
Average 86 stars, based on 1 article reviews
alternative commercially available pfo closure devices - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Distribution of Patent Foramen Ovale (PFO) closure devices. This pie chart illustrates the proportional distribution of the different occluder devices used in the study cohort (N = 130). The Amplatzer PFO Occluder was the most utilized device (69.2%, N = 90), followed by Occlutech (20.8%, n = 27), Cardiofix (5.4%, n = 7), and Biostar (4.6%, n = 6). Data are presented as percentages and absolute patient counts.

Journal: Journal of Clinical Medicine

Article Title: Long-Term Comparative Efficacy and Safety of Different Patent Foramen Ovale Closure Devices: Real-World Evidence from a 15-Year Cohort

doi: 10.3390/jcm15093429

Figure Lengend Snippet: Distribution of Patent Foramen Ovale (PFO) closure devices. This pie chart illustrates the proportional distribution of the different occluder devices used in the study cohort (N = 130). The Amplatzer PFO Occluder was the most utilized device (69.2%, N = 90), followed by Occlutech (20.8%, n = 27), Cardiofix (5.4%, n = 7), and Biostar (4.6%, n = 6). Data are presented as percentages and absolute patient counts.

Article Snippet: The second group was the other devices group: patients treated with alternative commercially available PFO closure devices (e.g., FIGULLA, BIOSTAR, CARDIOFIX).

Techniques: